Table 5 |
|||||
|
Indices of responsiveness after three months of follow-up in fibromyalgia patients |
|||||
|
Mean change |
Wilcoxon's test |
P value |
Effect size |
Standardised response mean |
|
|
|
|||||
|
Pain |
5.141 |
5.653 |
< 0.0001 |
0.535 |
0.606 |
|
Fatigue |
2.221 |
8.112 |
< 0.0001 |
0.787 |
0.778 |
|
Sleep |
1.682 |
5.765 |
0.0008 |
0.698 |
0.518 |
|
Stiffness |
1.864 |
5.785 |
0.0006 |
0.627 |
0.536 |
|
GH |
0.941 |
6.882 |
< 0.0001 |
0.581 |
0.444 |
|
TPS |
0.453 |
2.154 |
0.0312 |
0.191 |
0.151 |
|
SAPS |
1.312 |
9.911 |
< 0.0001 |
0.713 |
0.722 |
|
FAS |
1.431 |
10.015 |
< 0.0001 |
0.889 |
0.831 |
|
FIQ |
14.194 |
8.184 |
< 0.0001 |
0.781 |
0.819 |
|
SF-36 PCS |
2.594 |
-3.366 |
0.0006 |
0.321 |
0.285 |
|
SF-36 MCS |
5.029 |
-4.412 |
< 0.0001 |
0.434 |
0.384 |
|
|
|||||
|
The greatest improvements were in Fibromyalgia Assessment Status (FAS), and the smallest in tender point score (TPS) and Short Form 36 Health Survey (SF-36) physical component scale summary score (PCS) and mental component scale summary score (MCS). FIQ = Fibromyalgia Impact Questionnaire; GH = perceived general health; SAPS = Self-Assessment Pain Scale. |
|||||
|
Salaffi et al. Arthritis Research & Therapy 2009 11:R125 doi:10.1186/ar2792 |
|||||